These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3330985)

  • 21. Clinical trial of captopril (Aceten) in Indian patients with essential hypertension.
    Shah BP; Patel K; Oke VG; Raghu CN
    Int J Clin Pharmacol Ther Toxicol; 1986 Aug; 24(8):415-20. PubMed ID: 3531033
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Captopril/hydrochlorothiazide combination in elderly patients with mild-moderate hypertension. A double-blind, randomized, placebo-controlled study.
    Creisson C; Baulac L; Lenfant B
    Postgrad Med J; 1986; 62 Suppl 1():139-41. PubMed ID: 3534849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of replacing beta-blockers with an angiotensin converting enzyme inhibitor on the quality of life of hypertensive patients.
    Paran E; Anson O; Neumann L
    Am J Hypertens; 1996 Dec; 9(12 Pt 1):1206-13. PubMed ID: 8972892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of captopril with propranolol in the treatment of mild and moderate essential hypertension.
    Seedat YK
    S Afr Med J; 1979 Dec; 56(23):983-6. PubMed ID: 399093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects of the long-term treatment with losartan and captopril and of the abrupt cessation on circadian blood pressure profile].
    Gorbunov VM; Savina LV; Metelitsa VI; Deev AD
    Eksp Klin Farmakol; 2001; 64(2):45-50. PubMed ID: 11548448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative study of the efficacy of captopril at a single daily dose of 100 mg and at a twice daily dose of 50 mg by measuring ambulatory pressure over 24 hours.
    De Gaudemaris R; Battistella P; Siche JP; Debru JL; Blatier JF; Mallion JM
    Postgrad Med J; 1986; 62 Suppl 1():97-100. PubMed ID: 3534869
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effectiveness and tolerance of benazepril versus captopril in patients with hypertension].
    Ol'binskaia LI; Golubev SA; Morozova TE
    Klin Med (Mosk); 1995; 73(5):36-8. PubMed ID: 8815273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Review of studies on the clinical pharmacodynamics of cilazapril.
    Belz GG; Breithaupt K; Erb K
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S14-9. PubMed ID: 7898090
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Self-reported side effects from antihypertensive drugs. A clinical trial. Quality of Life Research Group.
    Schoenberger JA; Croog SH; Sudilovsky A; Levine S; Baume RM
    Am J Hypertens; 1990 Feb; 3(2):123-32. PubMed ID: 2407265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of antihypertensive effects of captopril and propranolol in essential hypertension.
    Huang CM; del Greco F; Quintanilla A; Molteni A
    JAMA; 1981 Feb; 245(5):478-82. PubMed ID: 7005474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Captopril and other angiotensin converting enzyme inhibitors in the treatment of hypertension].
    Hradec J
    Vnitr Lek; 1995 May; 41(5):336-9. PubMed ID: 7653065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evaluation by practicing physicians of the antihypertensive efficacy of debrisoquin, methyldopa and propranolol].
    Avigdor L; Waeber B; Brunner HR
    Schweiz Med Wochenschr; 1983 Mar; 113(9):331-8. PubMed ID: 6342133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Haemodynamic changes in peripheral arterial circulation during antihypertensive treatment with captopril, methyldopa and indapamide.
    Ferrara LA; Rubba P; Iannuzzi A; Fasano ML
    Int J Clin Pharmacol Res; 1984; 4(5):389-93. PubMed ID: 6394516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of antihypertensive combination therapy on lipid and glucose metabolism: hydrochlorothiazide plus sotalol vs. hydrochlorothiazide plus captopril.
    Middeke M; Richter WO; Schwandt P; Holzgreve H
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):231-4. PubMed ID: 9208337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Guanfacine versus alpha-methyldopa in benign essential hypertension. An ambulatory group study].
    Rhomberg F; Widler J
    Schweiz Med Wochenschr; 1981 Dec; 111(50):1967-8. PubMed ID: 7036334
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of captopril and propranolol, alone and in combination, on the responses to isometric and dynamic exercise in normotensive and hypertensive men.
    Ferguson RK; Vlasses PH; Koffer H; Clementi RA; Koplin JR; Willcox CM
    Pharmacotherapy; 1983; 3(2 Pt 1):125-30. PubMed ID: 6344035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of captopril (SQ 14225) with hydrochlorothiazide in the treatment of essential hypertension.
    Aberg H; Frithz G; Mörlin C
    Int J Clin Pharmacol Ther Toxicol; 1981 Aug; 19(8):368-71. PubMed ID: 7030977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of once-daily guanfacine and twice-a-day methyldopa in the treatment of mild to moderate hypertension.
    Farooki MS; Farsky K; Bouchard S; Lalonde Y; Brookman S
    Clin Ther; 1985; 7(2):199-204. PubMed ID: 3886142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Captopril as a replacement for multiple therapy in hypertension: a controlled study.
    Yodfat Y; Fidel J; Bloom DS
    J Hypertens Suppl; 1985 Nov; 3(2):S155-8. PubMed ID: 3910775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of amlodipine and captopril in hypertension based on 24-hour ambulatory monitoring.
    Lacourcière Y; Poirier L; Provencher P
    J Cardiovasc Pharmacol; 1993; 22 Suppl A():S20-3. PubMed ID: 7522283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.